Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 251(2023) vom: 01. Juni, Seite 109342
1. Verfasser: Shen, Ching-Fen (VerfasserIn)
Weitere Verfasser: Fu, Yi-Chen, Ho, Tzong-Shiann, Chen, Po-Lin, Lee, Nan-Yao, Tsai, Bo-Yang, Tsai, Pei-Jane, Ko, Wen-Chien, Liu, Ching-Chuan, Cheng, Chao-Min, Shieh, Chi-Chang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Adenovirus vector vaccine COVID-19 vaccines Heterologous prime-boost immunization Neutralizing antibody T cell response mRNA vaccine 2019-nCoV Vaccine mRNA-1273 EPK39PL4R4 mehr... Antibodies, Neutralizing Antibodies, Viral